Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K
Layers of Connective Tissue Proper01:21

Layers of Connective Tissue Proper

6.9K
Fascia, a thin layer of fibrous connective tissue, is distributed throughout the body. It demarcates and forms a supportive covering over skeletal muscles, bones, blood vessels, and organs. There are three main types of facia— superficial fascia, deep fascia, and subserous fascia. These are all present at different depths in the body. Fascia reduces the friction and permits muscles, joints, and organs to easily slide against each other, facilitating movement of the body and preventing...
6.9K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

4.8K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.8K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

1.0K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Low-Dose Naltrexone in Women With Fibromyalgia Syndrome: A 12-Month Randomised, Double-Blind, Placebo-Controlled Single-Centre Clinical Trial (INNOVA Study).

European journal of pain (London, England)·2026
Same author

Central noradrenergic deficiency in post-infectious chronic fatigue: neurobehavioral correlates.

Brain communications·2026
Same author

Effectiveness of Acceptance and Commitment Therapy (ACT) for the Management of Postsurgical Pain: A Randomized Controlled Trial (SPINE-ACT Study).

European journal of pain (London, England)·2026
Same author

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome diagnostic reporting in the 2021-2023 National Health Interview Survey.

BMC public health·2026
Same author

Reply to: "On the relation between the CSI-7 and central sensitization": Clarifying the purpose and interpretation of the Central Sensitization Inventory (CSI).

The journal of pain·2026
Same author

Beyond the Benefit of Doubt: Biases and Credibility in the Adjudication of Chronic Pain.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2026

Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.9K

Fibromyalgia.

Winfried Häuser1,2, Jacob Ablin3, Mary-Ann Fitzcharles4

  • 1Department of Internal Medicine 1, Klinikum Saarbrücken, Winterberg 1, D-66119 Saarbrücken, Germany.

Nature Reviews. Disease Primers
|May 19, 2016
PubMed
Summary
This summary is machine-generated.

Fibromyalgia is a chronic pain condition affecting 2-4% of the global population. Diagnosis and treatment involve a combination of non-pharmacological and pharmacological approaches tailored to individual symptoms.

More Related Videos

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
07:19

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

6.3K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.3K

Related Experiment Videos

Last Updated: Mar 21, 2026

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.9K
Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
07:19

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

6.3K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.3K

Area of Science:

  • Rheumatology
  • Pain Medicine
  • Patient-Reported Outcomes

Background:

  • Fibromyalgia is a complex chronic illness characterized by widespread pain, fatigue, sleep disturbances, and cognitive difficulties.
  • Its definition, pathogenesis, and treatment remain subjects of debate, with varying diagnostic criteria proposed over time.
  • Prevalence in the general population is estimated between 2% and 4%, though diagnosed cases are fewer.

Purpose of the Study:

  • To provide a comprehensive overview of fibromyalgia, including its definition, diagnostic criteria, and current understanding of pathogenesis.
  • To highlight the challenges and controversies surrounding fibromyalgia diagnosis and management.
  • To outline evidence-based multimodal treatment strategies for fibromyalgia.

Main Methods:

  • Review of existing literature and diagnostic criteria from organizations like the American College of Rheumatology (ACR).
  • Discussion of proposed models for fibromyalgia pathogenesis involving biological and psychosocial factors.
  • Synthesis of current evidence-based guidelines for multimodal treatment approaches.

Main Results:

  • The ACR has evolved its classification and diagnostic criteria, moving from tender point assessments to incorporating patient-reported symptoms.
  • Fibromyalgia pathogenesis is thought to involve an interaction of biological and psychosocial variables, though details are still unclear.
  • Multimodal treatments, combining non-pharmacological and pharmacological interventions, are emphasized for managing individual symptoms.

Conclusions:

  • Fibromyalgia is a recognized disorder with a significant prevalence, requiring careful diagnosis through symptom assessment and exclusion of other conditions.
  • Understanding the complex interplay of factors in fibromyalgia pathogenesis is crucial for effective management.
  • Tailored, multimodal treatment plans are essential for addressing the diverse symptoms experienced by fibromyalgia patients.